These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [ASS plus dipyridamole instead of ASS monotherapy. Risk for second stroke cut in half]. MMW Fortschr Med; 2004 Jul; 146(27-28):55. PubMed ID: 15526674 [No Abstract] [Full Text] [Related]
4. Antiplatelet treatment for secondary prevention of acute ischemic stroke and transient ischemic attacks: mechanisms, choices and possible emerging patterns of use. Moonis M; Fisher M Expert Rev Cardiovasc Ther; 2003 Nov; 1(4):611-5. PubMed ID: 15030260 [No Abstract] [Full Text] [Related]
5. [For which patient ASS, clopidogrel or dipyridamole? (interview by Dr. Med. Dirk Einecke)]. Diener HC MMW Fortschr Med; 2004 Jun; 146(24):50. PubMed ID: 15366496 [No Abstract] [Full Text] [Related]
6. [The combination of acetylsalicylic acid and dipyridamole is more effective in secondary prevention following transient ischaemic attack or cerebral infarction: the debate is closed]. Schrama E; Eusman JP Ned Tijdschr Geneeskd; 2006 Dec; 150(48):2672; author reply 2672-3. PubMed ID: 17205946 [No Abstract] [Full Text] [Related]
8. Cardiac safety in the European Stroke Prevention Study 2 (ESPS2). Diener HC; Darius H; Bertrand-Hardy JM; Humphreys M; Int J Clin Pract; 2001 Apr; 55(3):162-3. PubMed ID: 11351768 [TBL] [Abstract][Full Text] [Related]
9. ESPRIT: is aspirin plus dipyridamole superior to aspirin alone in TIA or minor stroke patients? Rouhl RP; Lodder J Expert Rev Neurother; 2008 Nov; 8(11):1661-5. PubMed ID: 18986236 [TBL] [Abstract][Full Text] [Related]
10. [The combination of acetylsalicylic acid and dipyridamole is more effective in secondary prevention following transient ischaemic attack or cerebral infarction: the debate is closed]. Offerhaus L Ned Tijdschr Geneeskd; 2006 Dec; 150(48):2673; author reply 2673-4. PubMed ID: 17205947 [No Abstract] [Full Text] [Related]
11. [Secondary prevention of ischemic insult and transient cerebral ischemia. Is ASS alone enough?]. Diener HC MMW Fortschr Med; 2003 May; 145 Suppl 2():111. PubMed ID: 14579505 [No Abstract] [Full Text] [Related]
12. Aspirin and dipyridamole for the secondary prevention of stroke. Zielinski R; French L J Fam Pract; 1999 Feb; 48(2):92. PubMed ID: 10037534 [No Abstract] [Full Text] [Related]
13. Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy. Biller J J Neurol Sci; 2009 Sep; 284(1-2):1-9. PubMed ID: 19380153 [TBL] [Abstract][Full Text] [Related]
14. [ASS and dipyridamole combination. A decisive contribution to secondary prevention after stroke]. Haberl R MMW Fortschr Med; 2003 May; 145 Suppl 2():98. PubMed ID: 14579496 [No Abstract] [Full Text] [Related]
15. [Secondary prevention of TIA and stroke. How much must thrombocytes not be inhibited?]. Einecke D MMW Fortschr Med; 2004 Jun; 146(24):50. PubMed ID: 15366495 [No Abstract] [Full Text] [Related]
16. Targeting the inflammatory response in secondary stroke prevention: a role for combining aspirin and extended-release dipyridamole. Weyrich AS; Skalabrin EJ; Kraiss LW Am J Ther; 2009; 16(2):164-70. PubMed ID: 19300042 [TBL] [Abstract][Full Text] [Related]
17. Secondary stroke prevention with antiplatelet therapy with emphasis on the cardiac patient: a neurologist's view. Gebel JM J Am Coll Cardiol; 2005 Sep; 46(5):752-5. PubMed ID: 16139120 [TBL] [Abstract][Full Text] [Related]
18. Antiplatelet therapy for the prevention of recurrent stroke and other serious vascular events: a review of the clinical trial data and guidelines. Hankey GJ Curr Med Res Opin; 2007 Jun; 23(6):1453-62. PubMed ID: 17559741 [TBL] [Abstract][Full Text] [Related]
19. Use of dipyridamole in patients with recent stroke or TIA. Bernstein RA Am Fam Physician; 2005 Aug; 72(3):382, 384; author reply 384. PubMed ID: 16100852 [No Abstract] [Full Text] [Related]
20. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial. Serebruany VL; Malinin AI; Pokov AN; Hanley DF Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]